USPTO Art Unit 1683 Prosecution Statistics

Art Unit Information

Art Unit: 1683
Group: 1680
Tech Center: 1600
Total Cases: 992
Last Active: June 2025

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19241820METHODS OF CAPTURING CELL-FREE METHYLATED DNA AND USES OF SAMEJune 2025February 2026Allow810YesNo
19236454GENERATION OF PHASED READ-SETS FOR GENOME ASSEMBLY AND HAPLOTYPE PHASINGJune 2025January 2026Allow810NoNo
19230110METHOD FOR DETECTING MOLECULAR CHARACTERISTIC OF GENE-EDITED DISEASE-RESISTANT PIG AND USE THEREOFJune 2025December 2025Allow720YesNo
19220155METHOD FOR DETECTING BI-ALLELIC GENE EDITED CELLS BASED ON CRISPR/CAS12A TECHNOLOGYMay 2025July 2025Allow200YesNo
19201039METHODS FOR EARLY DETECTION OF CANCERMay 2025September 2025Allow410NoNo
19192017DETECTION AND DIGITAL QUANTITATION OF MULTIPLE TARGETSApril 2025October 2025Allow611YesNo
19169801SAMPLE PREPARATION METHODApril 2025October 2025Allow720NoNo
19088508METHODS FOR DETECTING NUCLEIC ACID MOLECULES IN CELLSMarch 2025February 2026Allow1120NoNo
19073932SPATIALLY ENCODED BIOLOGICAL ASSAYSMarch 2025June 2025Allow400YesNo
19074001SPATIALLY ENCODED BIOLOGICAL ASSAYSMarch 2025July 2025Allow400NoNo
19053925IN SITU COMBINATORIAL LABELING OF CELLULAR MOLECULESFebruary 2025June 2025Allow410NoNo
19049943DETECTION AND DIGITAL QUANTITATION OF MULTIPLE TARGETSFebruary 2025September 2025Allow720YesNo
19048060MULTIOMIC ANALYSIS DEVICE AND METHODS OF USE THEREOFFebruary 2025May 2025Allow400NoNo
18991325ANALYSIS OF A POLYMERDecember 2024September 2025Allow910NoNo
18988274COMPOSITIONS AND METHODS FOR NUCLEIC ACID SEQUENCINGDecember 2024September 2025Allow910NoNo
18987997METHOD FOR TRANSPOSASE-MEDIATED SPATIAL TAGGING AND ANALYZING GENOMIC DNA IN A BIOLOGICAL SAMPLEDecember 2024April 2025Allow400YesNo
18988119METHOD FOR TRANSPOSASE-MEDIATED SPATIAL TAGGING AND ANALYZING GENOMIC DNA IN A BIOLOGICAL SAMPLEDecember 2024April 2025Allow400YesNo
18985984METHODS FOR EARLY DETECTION OF CANCERDecember 2024January 2026Allow1320NoNo
18978794METHODS FOR IN SITU TRANSCRIPTOMICS AND PROTEOMICSDecember 2024September 2025Allow910NoNo
18972052SPATIALLY ENCODED BIOLOGICAL ASSAYSDecember 2024March 2025Allow300YesNo
18972148SPATIALLY ENCODED BIOLOGICAL ASSAYSDecember 2024April 2025Allow400NoNo
18940111MICROFLUIDIC DEVICE AND METHOD OF MANUFACTURING THE SAMENovember 2024February 2025Allow300NoNo
18926208COMPOSITIONS AND METHODS FOR GENE EXPRESSION LIBRARY ANALYSISOctober 2024January 2025Allow300YesNo
18914833METHODS, COMPOSITIONS, AND KITS FOR DETERMINING THE LOCATION OF MULTIPLE ANALYTES IN A BIOLOGICAL SAMPLEOctober 2024December 2025Allow1410NoNo
18824062METHOD AND APPARATUS FOR PROCESSING TISSUE AND OTHER SAMPLES ENCODING CELLULAR SPATIAL POSITION INFORMATIONSeptember 2024September 2025Allow1201YesNo
18820166CANCER DETECTION AND CLASSIFICATION USING METHYLOME ANALYSISAugust 2024October 2025Allow1310YesNo
18793359SPATIALLY ENCODED BIOLOGICAL ASSAYSAugust 2024December 2024Allow500YesNo
18792527MULTIPLEXED PROFILING OF RNA AND DNA MODIFICATIONSAugust 2024July 2025Allow1110NoNo
18789541METHODS AND SYSTEMS FOR TARGETED RNA CLEAVAGE AND TARGET RNA-PRIMED ROLLING CIRCLE AMPLIFICATIONJuly 2024February 2025Allow610YesNo
18759368DETECTION AND DIGITAL QUANTITATION OF MULTIPLE TARGETSJune 2024November 2024Allow510YesNo
18745574DETECTION AND DIGITAL QUANTITATION OF MULTIPLE TARGETSJune 2024February 2025Allow810NoNo
18663425APPARATUS AND METHODS FOR IDENTIFICATION OF MICROBIAL PRESENCEMay 2024November 2024Allow600YesNo
18649255METHODS, COMPOSITIONS, AND KITS FOR DETERMINING THE LOCATION OF AN ANALYTE IN A BIOLOGICAL SAMPLEApril 2024February 2025Allow910NoNo
18606093COLORECTAL CANCER DETECTION KIT OR DEVICE, AND DETECTION METHODMarch 2024February 2026Allow2300NoNo
18604659PROSTATE CANCER DETECTION KIT OR DEVICE, AND DETECTION METHODMarch 2024July 2025Allow1600NoNo
18602633MOLECULAR WIRES FOR DETECTING A BIOLOGICAL OR CHEMICAL ENTITY OR EVENTMarch 2024August 2024Allow510NoNo
18589354COMPOSITIONS AND METHODS FOR GENE EXPRESSION LIBRARY ANALYSISFebruary 2024August 2024Allow610YesNo
18443079METHODS FOR IN SITU TRANSCRIPTOMICS AND PROTEOMICSFebruary 2024February 2025Allow1220NoNo
18441187METHODS FOR EARLY DETECTION OF CANCERFebruary 2024June 2024Allow410NoNo
18431748MULTIVALENT BINDING COMPOSITION FOR NUCLEIC ACID ANALYSISFebruary 2024January 2025Allow1111YesNo
18417995OPTICAL SYSTEMS FOR NUCLEIC ACID SEQUENCING AND METHODS THEREOFJanuary 2024July 2024Allow610NoNo
18416797ANALYTE SEQUENCING WITH NANOPORESJanuary 2024August 2025Allow1921NoNo
18577460DEVICES, KITS, AND METHODS FOR DETERMINING INCREASED SUSCEPTIBILITY TO AND TREATMENT AND PREVENTION OF PERIODONTITIS, ALZHEIMER’S DISEASE, AND OTHER CONDITIONSJanuary 2024November 2025Abandon2221NoNo
18405371LUNG CANCER DETECTION KIT OR DEVICE, AND DETECTION METHODJanuary 2024April 2025Allow1600NoNo
18389901IN SITU COMBINATORIAL LABELING OF CELLULAR MOLECULESDecember 2023October 2024Allow1010NoNo
18539226MICROFLUIDIC DEVICE AND METHOD OF MANUFACTURING THE SAMEDecember 2023August 2024Allow801NoNo
18538488NON-INVASIVE DETECTION OF FETAL GENETIC TRAITSDecember 2023April 2025Abandon1620NoNo
18514603BREAST CANCER DETECTION KIT OR DEVICE, AND DETECTION METHODNovember 2023April 2025Allow1700NoNo
18509767STOMACH CANCER DETECTION KIT OR DEVICE, AND DETECTION METHODNovember 2023March 2025Allow1600NoNo
18502378BIOMARKER FOR PREDICTING AGE IN DAYS OF PIGS, AND PREDICTION METHODNovember 2023April 2025Abandon1821NoNo
18491272LIVER CANCER DETECTION KIT OR DEVICE, AND DETECTION METHODOctober 2023August 2024Allow1000YesNo
18479622MULTIPLEXED PROFILING OF RNA AND DNA MODIFICATIONSOctober 2023February 2025Allow1711YesNo
18473061DNA Damage Repair Inhibitors for Treatment of CancerSeptember 2023March 2025Abandon1801NoNo
18469871IN SITU DETECTION OF NUCLEIC ACID MOLECULESSeptember 2023February 2025Allow1720NoNo
18243582METHODS FOR IMPROVED IN SITU DETECTION OF NUCLEIC ACIDS AND SPATIAL ANALYSISSeptember 2023August 2024Allow1221YesNo
18455537METHODS OF MONITORING IMMUNOSUPPRESSIVE THERAPIES IN A TRANSPLANT RECIPIENTAugust 2023September 2025Abandon2521NoNo
18455517METHODS OF MONITORING IMMUNOSUPPRESSIVE THERAPIES IN A TRANSPLANT RECIPIENTAugust 2023September 2025Abandon2521NoNo
18455499METHODS OF MONITORING IMMUNOSUPPRESSIVE THERAPIES IN A TRANSPLANT RECIPIENTAugust 2023September 2025Abandon2521NoNo
18455488METHODS OF MONITORING IMMUNOSUPPRESSIVE THERAPIES IN A TRANSPLANT RECIPIENTAugust 2023May 2025Abandon2021NoNo
18455480METHODS OF MONITORING IMMUNOSUPPRESSIVE THERAPIES IN A TRANSPLANT RECIPIENTAugust 2023September 2025Abandon2521NoNo
18455462METHODS OF MONITORING IMMUNOSUPPRESSIVE THERAPIES IN A TRANSPLANT RECIPIENTAugust 2023September 2025Abandon2521NoNo
18455527METHODS OF MONITORING IMMUNOSUPPRESSIVE THERAPIES IN A TRANSPLANT RECIPIENTAugust 2023June 2025Abandon2231NoNo
18455456METHODS OF MONITORING IMMUNOSUPPRESSIVE THERAPIES IN A TRANSPLANT RECIPIENTAugust 2023June 2025Abandon2231NoNo
18361440BILIARY TRACT CANCER DETECTION KIT OR DEVICE, AND DETECTION METHODJuly 2023July 2024Allow1200NoNo
18355291RNA TEMPLATED LIGATIONJuly 2023September 2024Allow1410YesNo
18352957MULTIOMIC ANALYSIS DEVICE AND METHODS OF USE THEREOFJuly 2023January 2025Allow1831NoNo
18349684INTEGRATED SAMPLE PROCESSING SYSTEMJuly 2023January 2026Abandon3111NoNo
18348072METHOD FOR TRANSPOSASE-MEDIATED SPATIAL TAGGING AND ANALYZING GENOMIC DNA IN A BIOLOGICAL SAMPLEJuly 2023November 2024Allow1630YesNo
18345629METHODS AND SYSTEMS FOR SPATIAL MAPPING OF GENETIC VARIANTSJune 2023September 2024Allow1410YesNo
18345861CLOSED NUCLEIC ACID STRUCTURESJune 2023October 2025Abandon2720NoNo
18215608SMALL RNA PREDICTORS FOR HUNTINGTON'S DISEASEJune 2023February 2025Abandon2001NoNo
18343028RNA AND DNA ANALYSIS USING ENGINEERED SURFACESJune 2023November 2024Allow1711YesNo
18215011SEQUENCING CONCATEMERS OF COPIES OF SENSE AND ANTISENSE STRANDSJune 2023March 2026Abandon3310NoNo
18210970IN SITU SEQUENCING OF RNA TRANSCRIPTS WITH NON-UNIFORM 5 PRIME ENDSJune 2023August 2024Allow1421YesNo
18210119GENE SPECIFIC SPATIAL ROLLING CIRCLE AMPLIFICATION AND NGS SEQUENCINGJune 2023March 2026Allow3310YesNo
18335936MULTIPLEXED TARGETED AMPLIFICATION OF POLYNUCLEOTIDESJune 2023September 2024Allow1521YesNo
18328489AFFINITY REAGENTS HAVING ENHANCED BINDING AND DETECTION CHARACTERISTICSJune 2023December 2025Allow3040YesNo
18327822MULTIPLEXED INSTRUMENT-FREE BAR-CHART ROTARY CHIP INTEGRATED WITH NANOPARTICLE-MEDIATED APTASENSORS FOR VISUAL QUANTITATIVE DETECTION OF MULTIPLE PATHOGENSJune 2023December 2025Abandon3011NoNo
18204757CHOOSING APPROPRIATE KINSHIP BETWEEN PATIENT AND EGG OR SPERM DONOR FOR MEDICALLY ASSISTED PREGNANCYJune 2023January 2026Abandon3111NoNo
18324880HIGH THROUGHPUT MULTIOMICS SAMPLE ANALYSISMay 2023May 2025Allow2420NoNo
18324890HIGH THROUGHPUT MULTIOMICS SAMPLE ANALYSISMay 2023May 2025Allow2420NoNo
18323922CANCER TREATMENTS AND METHODS OF SELECTING SAMEMay 2023April 2025Abandon2301NoNo
18318404METHODS OF GENERATING NANOARRAYS AND MICROARRAYSMay 2023September 2025Abandon2901NoNo
18313256METHODS AND COMPOSITIONS FOR IN SITU ANALYSIS OF V(D)J SEQUENCESMay 2023October 2025Allow2910NoNo
18304695IN SITU COMBINATORIAL LABELING OF CELLULAR MOLECULESApril 2023August 2024Allow1610NoNo
18304670IN SITU COMBINATORIAL LABELING OF CELLULAR MOLECULESApril 2023August 2024Allow1610YesNo
18191522GENOMIC ALTERATIONS ASSOCIATED WITH SCHIZOPHRENIA AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAMEMarch 2023July 2025Abandon2811NoNo
18124212SELECTIVE PROTECTION OF NUCLEIC ACIDSMarch 2023March 2026Abandon3610NoNo
18245610METHOD FOR ANALYZING CELL RELEASED BIOMOLECULESMarch 2023March 2026Abandon3601NoNo
18185154METHODS AND USES OF INFLAMMATORY BOWEL DISEASE BIOMARKERSMarch 2023January 2025Abandon2211NoNo
18182225METHODS AND SYSTEMS FOR INTEGRATED ON-CHIP SINGLE-MOLECULE DETECTIONMarch 2023August 2025Abandon2950YesNo
18181397METHODS OF GENERATING NANOARRAYS AND MICROARRAYSMarch 2023July 2025Abandon2941YesNo
18179184RNA QUALITY ASSAYMarch 2023January 2026Abandon3421NoNo
18177238MULTIOMIC ANALYSIS DEVICE AND METHODS OF USE THEREOFMarch 2023January 2025Allow2240NoNo
18174121TWO-PART MEDIATOR PROBEFebruary 2023January 2026Abandon3521YesNo
18170241ASSOCIATION OF GENETIC VARIATIONS TO DIAGNOSE AND TREAT ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD)February 2023July 2024Allow1711YesNo
18167807DIAGNOSTIC ASSAY FOR TISSUE TRANSPLANTATION STATUSFebruary 2023March 2026Allow3721YesNo
18160918SYSTEMS AND METHODS FOR DETECTING MULTI-MOLECULE BIOMARKERSJanuary 2023September 2024Allow1921YesNo
18097012PEPTIDE NUCLEIC ACID FUNCTIONALIZED HYDROGEL MICRONEEDLES FOR SAMPLING AND DETECTION OF INTERSTITIAL FLUID NUCLEIC ACIDSJanuary 2023December 2025Abandon3621YesNo
18096975METHODS AND COMPOSITIONS FOR CELL-PROLIFERATION-RELATED DISORDERSJanuary 2023February 2025Abandon2501NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for art-unit 1683.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
16
Examiner Affirmed
11
(68.8%)
Examiner Reversed
5
(31.2%)
Reversal Percentile
44.5%
Lower than average

What This Means

With a 31.2% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
106
Allowed After Appeal Filing
38
(35.8%)
Not Allowed After Appeal Filing
68
(64.2%)
Filing Benefit Percentile
69.0%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 35.8% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Art Unit 1683 - Prosecution Statistics Summary

Executive Summary

Art Unit 1683 is part of Group 1680 in Technology Center 1600. This art unit has examined 992 patent applications in our dataset, with an overall allowance rate of 88.4%. Applications typically reach final disposition in approximately 42 months.

Comparative Analysis

Art Unit 1683's allowance rate of 88.4% places it in the 86% percentile among all USPTO art units. This art unit has a significantly higher allowance rate than most art units at the USPTO.

Prosecution Patterns

Applications in Art Unit 1683 receive an average of 2.50 office actions before reaching final disposition (in the 87% percentile). The median prosecution time is 42 months (in the 9% percentile).

Strategic Considerations

When prosecuting applications in this art unit, consider the following:

  • The art unit's allowance rate suggests a more favorable examination environment compared to the USPTO average.
  • With more office actions than average, plan for multiple rounds of prosecution.
  • The median prosecution time is longer than average and should be factored into your continuation and client communication strategies.
  • Review individual examiner statistics within this art unit to identify examiners with particularly favorable or challenging prosecution patterns.

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.